Compare Diagnos, Inc. with Similar Stocks
Stock DNA
Computers - Software & Consulting
CAD 24 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.61
-457.90%
24.08
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2026)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
111.36%
0%
111.36%
6 Months
74.81%
0%
74.81%
1 Year
138.46%
0%
138.46%
2 Years
-30.18%
0%
-30.18%
3 Years
-79.78%
0%
-79.78%
4 Years
-3.12%
0%
-3.12%
5 Years
-8.1%
0%
-8.1%
Diagnos, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-4.36%
EBIT Growth (5y)
-32.91%
EBIT to Interest (avg)
-2.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.05
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.46%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
24.08
EV to EBIT
-5.52
EV to EBITDA
-5.69
EV to Capital Employed
23.47
EV to Sales
23.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-425.32%
ROE (Latest)
-457.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Mar 2020
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.46%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.10
-1.00
-10.00%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.20
-1.20
Operating Profit Margin (Excl OI)
-72,657.20%
-70,011.10%
-264.61%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -9.09% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
0.10
0.10
Operating Profit (PBDIT) excl Other Income
-4.10
-3.70
-10.81%
Interest
0.40
0.60
-33.33%
Exceptional Items
0.00
0.10
-100.00%
Consolidate Net Profit
-4.60
-4.30
-6.98%
Operating Profit Margin (Excl OI)
-65,105.20%
-36,748.20%
-2,835.70%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 0.00% vs -50.00% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -6.98% vs -38.71% in Mar 2025
About Diagnos, Inc. 
Diagnos, Inc.
Computers - Software & Consulting
DIAGNOS Inc. provides data mining and interpretation consulting services, and designs data analytics software products. The Company operates through two segments: Healthcare and Natural resources. Its Healthcare segment offers image analysis services through Computer Assisted Retinal Analysis (CARA), a software tool, which assists health specialists in the detection of diabetic retinopathy. CARA is a hosted Web-based application that integrates fundus cameras with an image processing engine over an Internet connection. Its Natural resources segment offers data mining consulting services through Computer Aided Resource Detection System (CARDS), a software tool used to assist exploration companies in identifying mining deposits. In addition, it offers project management services. The Company operates in Canada, the United Arab Emirates, India, Mexico, Switzerland, the United States, Poland and Colombia.
Company Coordinates 
Company Details
7005 Taschereau Blvd Suite 340 , BROSSARD QC : J4Z 1A7
Registrar Details






